Go to the list of all blogs
Allana's Avatar
published in Blogs
Jul 28, 2026
Why Is Amkor Technology (AMKR) Stock Down -24.08% Today?

Why Is Amkor Technology (AMKR) Stock Down -24.08% Today?

Key Takeaways

  • Amkor Technology shares plunged 24.08% to $46.09 in Tuesday's session, extending a brutal sell-off that began after the company's second-quarter earnings report.
  • The primary catalyst was weaker-than-expected third-quarter revenue guidance, issued alongside otherwise strong Q2 results, with the company forecasting $1.95–$2.05 billion versus the Street's $2.12 billion consensus estimate.
  • Communications segment weakness — driven by Android memory supply constraints and an ongoing system-in-package (SiP) production migration from Korea to Vietnam — emerged as a major headwind souring investor sentiment.
  • Broader semiconductor sector weakness compounded the sell-off, with semiconductor stocks lagging the broader market on Tuesday.
  • The stock has now fallen more than 52% from its 52-week high of $96.68, and traders are closely watching whether the $45 level can provide technical support after today's rout.

Opening Summary

AMKR — Amkor Technology, Inc., a leading global provider of outsourced semiconductor packaging and test (OSAT) services — saw its shares crater 24.08% on Tuesday, tumbling from Monday's closing price of $60.71 to an intraday level of $46.09. The collapse extends a multi-session rout that began after the company reported second-quarter fiscal 2026 results on Monday after the closing bell. While Amkor delivered record quarterly revenue of $1.90 billion and earnings per share of $0.70 that handily beat analyst estimates, it was the company's softer-than-expected third-quarter revenue outlook — combined with mounting communications segment headwinds — that triggered the massive sell-off. The stock had already dropped 6.54% during Monday's regular session and continued to deteriorate in after-hours and pre-market trading before accelerating sharply during Tuesday's session.

Q2 Results Topped Estimates, but Q3 Revenue Guidance Disappointed

Amkor's second-quarter numbers were impressive on the surface. Revenue surged 26% year-over-year to a record $1.90 billion, surpassing the analyst consensus of roughly $1.81 billion. Earnings per diluted share came in at $0.70, nearly 49% above the $0.47 Street estimate. Gross margin expanded more than 250 basis points sequentially to 16.8%, driven by higher factory utilization — which climbed from the 50% range into the 70% range — and an improving product mix tilted toward advanced packaging. Computing and automotive/industrial end markets each posted record quarterly revenue, with computing surging 20% sequentially on AI data-center demand.

Despite the beat, the company's third-quarter revenue guidance of $1.95 billion to $2.05 billion fell meaningfully short of the $2.12 billion consensus. Though EPS guidance of $0.72 to $0.82 exceeded the $0.66 analyst expectation, markets fixated on the top-line shortfall. The guidance miss signaled that near-term headwinds were accelerating faster than the company's strong advanced-packaging momentum could offset, prompting a sharp re-rating of the stock.

Communications Weakness and SiP Migration Disruption

The single largest drag on Amkor's outlook is the communications segment, which represents roughly 42% of total revenue. On the earnings call, CEO Kevin Engel revealed that Android revenue had already declined 20% in the second quarter, pressured by memory supply chain constraints and shifting customer build patterns. Management guided for communications revenue to decline by a high-single-digit percentage sequentially in Q3 — an unusual seasonal pattern for a quarter that typically benefits from smartphone production ramps.

Compounding the market-driven softness, Amkor is in the midst of a strategic migration of its system-in-package (SiP) production from Korea to Vietnam. While management framed the move as a long-term efficiency initiative that frees up Korean capacity for higher-value computing programs, the near-term disruption is proving painful. Engel cautioned that the SiP transition would not be a one-quarter event, with headwinds expected to persist through the fourth quarter and into the first half of 2027. The lack of clear near-term visibility around this operational disruption appeared to be a tipping point for investors already on edge.

Sector and Broader Market Pressure

Amkor's plunge did not occur in isolation. The semiconductor sector was Tuesday's worst-performing group, with the group down roughly 6.3% on the day. The stock's sell-off was further amplified by technical breakdowns: with today's decline, AMKR has now decisively sliced below both its 50-day moving average of approximately $73 and its 200-day moving average near $61, triggering additional momentum-based selling. Broader market indices showed mixed performance, confirming that Amkor's decline was driven primarily by company-specific and sector-specific factors rather than a broad market pullback.

Volume was exceptionally elevated on Tuesday, following Monday's already heavy trading of over 10.8 million shares — roughly double the stock's 10-day average volume of approximately 5.1 million shares. The surge in selling volume underscored the conviction behind the move and suggested institutional repositioning away from the name.

What Comes Next for AMKR

Investors now face a delicate balancing act when evaluating AMKR shares. On one hand, the company's strategic positioning in advanced packaging — anchored by a 10-year agreement with TSMC and a multi-year partnership with NVIDIA — provides a credible long-term growth narrative tied to AI and high-performance computing. The computing segment is expected to grow nearly 30% sequentially in Q3, and gross margins are projected to expand further to 18.5%–19.5%.

On the other hand, the communications overhang and SiP migration disruption will likely keep sentiment in check for multiple quarters. Management acknowledged that Phase 1 of the Arizona facility is fully committed, but the ramp of that capacity is expected to create margin headwinds in 2027 and 2028 due to underutilization costs. With the stock now trading at levels not seen since early 2026, the burden of proof has shifted firmly onto management to demonstrate that the current operational disruptions are transitory and that the advanced-packaging growth trajectory remains intact.

Trending AI Robots

In volatile market environments like the one currently affecting semiconductor stocks, traders increasingly turn to algorithmic and AI-driven strategies to navigate price swings. Tickeron offers hundreds of AI trading bots covering thousands of tickers across multiple strategies, timeframes, and performance profiles. The Trending AI Robots page curates only the strongest-performing bots under current market conditions, giving users a streamlined way to explore which automated strategies are adapting best to today's fast-moving landscape. Each bot varies by trading style, holding period, and tracked symbols, allowing traders to align their approach with real-time market dynamics.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AMKR

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


AMKR in upward trend: price expected to rise as it breaks its lower Bollinger Band on July 28, 2026

AMKR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 37 cases where AMKR's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AMKR's RSI Oscillator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 62 cases where AMKR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where AMKR advanced for three days, in of 324 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMKR as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

AMKR moved below its 50-day moving average on July 02, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AMKR crossed bearishly below the 50-day moving average on July 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMKR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AMKR entered a downward trend on August 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.894) is normal, around the industry mean (8.253). P/E Ratio (24.287) is within average values for comparable stocks, (173.765). AMKR's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.534). Dividend Yield (0.006) settles around the average of (0.006) among similar stocks. P/S Ratio (1.812) is also within normal values, averaging (35.325).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AMKR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 64, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are Applied Materials (NASDAQ:AMAT), Lam Research Corp (NASDAQ:LRCX), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 64.45B. The market cap for tickers in the group ranges from 555.66K to 663.18B. ASML holds the highest valuation in this group at 663.18B. The lowest valued company is AVSR at 555.66K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was 8%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 46%. AXTI experienced the highest price growth at 60%, while SMTK experienced the biggest fall at -26%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was -47%. For the same stocks of the Industry, the average monthly volume growth was -41% and the average quarterly volume growth was -68%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 34
Price Growth Rating: 43
SMR Rating: 74
Profit Risk Rating: 64
Seasonality Score: -23 (-100 ... +100)
View a ticker or compare two or three
AMKR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of outsourced semiconductor packaging and test services

Industry ElectronicProductionEquipment

Profile
Details
Industry
Semiconductors
Address
2045 East Innovation Circle
Phone
+1 480 821-5000
Employees
30800
Web
https://www.amkor.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.